全体要約
核酸医薬品原料は、DNAやRNAなどの遺伝情報を制御する物質を利用した医薬品であり、従来の低分子薬や抗体医薬品ではターゲットにできないmRNAやmiRNAを狙うことができる。2022年の世界の核酸医薬品原料市場は、地域や市場セクターごとに分析され、2023年から2029年の予測が示されている。アメリカ、中国、ヨーロッパの市場もそれぞれ成長が見込まれている。
この市場には、Danaher Corporation、Merck、Eurofins Scientificなどの主要企業が含まれ、2022年には上位2社が市場の大部分を占めている。市場はASO、siRNAなどのタイプや、研究、製薬などの用途に分かれており、地域別の成長機会も詳細に分析されている。
関連する質問
Danaher Corporation, Merck, Eurofins Scientific, Thermo Fisher Scientific, Agilent Technologies, GE Healthcare, Kaneka Eurogentec, GeneDesign, LGC Biosearch Technologies, Bio-synthesis, Guangzhou RiboBio, STA Pharmaceutical, Hongene Biotech
次世代医薬品としての期待, mRNAおよびmiRNAの標的化, 研究の活発化
概要
LPI (LP Information)の最新の調査報告書「核酸医薬品原材料産業予測」では、過去の販売を調査し、2022年の世界の核酸医薬品原材料の総販売をレビューしています。そして、2023年から2029年にかけての地域別および市場セクター別の核酸医薬品原材料の販売予測に関する包括的な分析を提供。地域、市場セクターおよびサブセクター別に分けられた核酸医薬品原材料の販売に基づき、この報告書は、世界の核酸医薬品原材料産業の詳細な分析を百万米ドル単位で提供。
このインサイトレポートは、世界の核酸医薬品原材料の動向を包括的に分析し、製品セグメンテーション、企業形成、収益、市場シェア、最新の開発、M&A活動に関連する主要なトレンドを強調しています。このレポートでは、核酸医薬品原材料ポートフォリオと能力、市場参入戦略、市場ポジション、および地理的なフットプリントに焦点を当て、急速に成長する世界の核酸医薬品原材料市場におけるリーディンググローバル企業の戦略を分析しています。
このインサイトレポートは、核酸医薬品原材料の世界的な見通しを形成する主要な市場動向、要因、影響要因を評価し、タイプ、アプリケーション、地理、及び市場規模別に予測を分解して、新たな機会の存在を浮き彫りにします。数百のボトムアップの定性的及び定量的市場データに基づいた透明な手法を用いたこの調査予測は、現在の状況及び核酸医薬品原材料の将来の軌道に関する非常に微妙な見解を提供します。
グローバルな核酸医薬品原料市場の規模は、2022年のXX米ドルから2029年のXX米ドルに成長すると予測されています。また、2023年から2029年の間にCAGR %で成長することが期待されています。
米国の核酸医薬品原材料市場は、2022年のXX米ドルから2029年にはXX米ドルに増加する見込みであり、2023年から2029年の間にXX%の CAGR を記録します。
中国における核酸医薬品原料市場は、2022年のXX米ドルから2029年までにXX米ドルに増加し、2023年から2029年の間にXX%のCAGRで成長することが見込まれています。
ヨーロッパの核酸医薬品原料市場は、2022年のXX米ドルから2029年のXX米ドルに増加する見込みであり、2023年から2029年の間にXX%の CAGRを記録する見込みです。
グローバルな主要な核酸医薬品原材料のプレーヤーには、ダナハー・コーポレーション、メルク、ユーロフィン・サイエンティフィック、サーモフィッシャー・サイエンティフィック、アジレント・テクノロジーズ、GEヘルスケア、カネカ・ユーロジェンテック、ジーンドザイン、LGCバイオサーチ・テクノロジーズなどが含まれます。収益の観点から、2022年には、世界の2大企業がほぼXX%のシェアを占めました。
この報告書は、核酸医薬品原材料市場の製品タイプ、用途、主要メーカー、主要地域および国による包括的な概要、市場シェア、および成長機会を示しています。
市場セグメンテーション
タイプ別のセグメンテーション
ASO
siRNA
その他
用途別セグメンテーション
調査
製薬業界
その他
この報告書では、市場を地域ごとに分割しています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
プロファイルされた以下の企業は、プライマリーエキスパートから得られた情報や、企業のカバレッジ、製品ポートフォリオ、市場浸透率の分析に基づいて選定されています。
ダナハーコーポレーション
メルク
ユーロフィンズ・サイエンティフィック
サーモフィッシャーサイエンティフィック
アジレント・テクノロジーズ
GEヘルスケア
カネカEurogentec
ジーンドザイン
LGCバイオサーチテクノロジーズ
バイオ合成
広州リボバイオ
STA製薬
ホンゲンバイオテック
本報告書で扱われた重要な質問
グローバル核酸医薬品原材料市場の10年間の見通しは何ですか？
ヌクレオチド薬原料市場の成長を促進している要因、世界および地域別。
どのテクノロジーが市場と地域によって最も急速に成長する準備ができていますか？
核酸医薬品原料の市場機会は、最終市場の規模によってどのように異なりますか？
核酸医薬品原料のタイプ、用途の内訳はどのようになっていますか？
COVID-19およびロシア・ウクライナ戦争の影響は何ですか？
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの核酸医薬品原料、年間売上、2018年～2029年
2.1.2 核酸医薬品原料の世界市場の現状分析・将来予測、地理別、2018年、2022年および2029年
2.1.3 核酸医薬品原料の世界市場の現状分析・将来予測、国・地域別、2018年、2022年および2029年
2.2 核酸医薬品原料セグメント、タイプ別
2.2.1 阿蘇
2.2.2 siRNA
2.2.3 その他
2.3 核酸医薬品原料の売上、タイプ別
2.3.1 グローバルにおける核酸医薬品原料の売上・市場シェア、タイプ別（2018年～2023年）
2.3.2 核酸医薬品原料のグローバルレベニュー・市場シェア、タイプ別（2018～2023年）
2.3.3 グローバルの核酸医薬品原料、販売価格（タイプ別）（2018年～2023年）
2.4 核酸医薬品原料セグメント、用途別
2.4.1 リサーチ
2.4.2 医薬品
2.4.3 その他
2.5 核酸医薬品原料の売上、用途別
2.5.1 グローバルの核酸医薬品原料、収益・市場シェア（用途別）（2018年～2023年）
2.5.2 核酸医薬品原料のグローバルレベニュー・市場シェア、用途別（2018～2023年）
2.5.3 グローバルの核酸医薬品原料、販売価格（用途別）（2018年～2023年）
3 グローバルにおける核酸医薬品原料、企業別
3.1 グローバルにおける核酸医薬品原料市場のブレークダウンデータ、企業別
3.1.1 グローバルにおける核酸医薬品原料の年間売上、企業別（2018年～2023年）
3.1.2 グローバルにおける核酸医薬品原料の売上・市場シェア、企業別（2018年～2023年）
3.2 グローバルにおける核酸医薬品原料の年間収益、企業別（2018年～2023年）
3.2.1 グローバルにおける核酸医薬品原料市場の収益規模、企業別（2018年～2023年）
3.2.2 グローバルにおける核酸医薬品原料市場の収益シェア、企業別（2018年～2023年）
3.3 グローバルにおける核酸医薬品原料の販売価格、企業別
3.4 核酸医薬品原料の主要メーカー、生産地域分布、販売地域、製品タイプ
3.4.1 核酸医薬品原料の主要メーカー、製品と拠点の分布
3.4.2 プレイヤーが提供している核酸医薬品原料製品
3.5 市場集中度分析
3.5.1 競合情勢分析
3.5.2 集中度レシオ（CR3、CR5、CR10）（2018年～2023年）
3.6 新製品・潜在的参入
3.7 M&A、拡大
4 核酸医薬品原料の世界市場過去推移レビュー、地理別
4.1 核酸医薬品原料の世界市場規模の過去推移、地理別（2018年～2023年）
4.1.1 グローバルにおける核酸医薬品原料の年間売上、地理別（2018年～2023年）
4.1.2 グローバルにおける核酸医薬品原料の年間収益、地理別（2018年～2023年）
4.2 核酸医薬品原料の世界市場規模の過去推移、国・地域別（2018年～2023年）
4.2.1 グローバルにおける核酸医薬品原料の年間売上、国・地域別（2018年～2023年）
4.2.2 グローバルにおける核酸医薬品原料の年間収益、国・地域別（2018年～2023年）
4.3 アメリカズにおける核酸医薬品原料の売上成長
4.4 APACにおける核酸医薬品原料の売上成長
4.5 ヨーロッパにおける核酸医薬品原料の売上成長
4.6 中東・アフリカにおける核酸医薬品原料の売上成長
5 アメリカズ
5.1 アメリカズにおける核酸医薬品原料の売上、国別
5.1.1 アメリカズにおける核酸医薬品原料の売上規模、国別（2018年～2023年）
5.1.2 アメリカズにおける核酸医薬品原料市場の収益規模、国別（2018年～2023年）
5.2 アメリカズにおける核酸医薬品原料の売上、タイプ別
5.3 アメリカズにおける核酸医薬品原料の売上、用途別
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおける核酸医薬品原料の売上、地域別
6.1.1 APACにおける核酸医薬品原料の売上規模、地域別（2018年～2023年）
6.1.2 APACにおける核酸医薬品原料市場の収益規模、地域別（2018年～2023年）
6.2 APACにおける核酸医薬品原料の売上、タイプ別
6.3 APACにおける核酸医薬品原料の売上、用途別
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
6.10 中国の台湾
7 ヨーロッパ
7.1 ヨーロッパにおける核酸医薬品原料、国別
7.1.1 ヨーロッパにおける核酸医薬品原料の売上規模、国別（2018年～2023年）
7.1.2 ヨーロッパにおける核酸医薬品原料市場の収益規模、国別（2018年～2023年）
7.2 ヨーロッパにおける核酸医薬品原料の売上、タイプ別
7.3 ヨーロッパにおける核酸医薬品原料の売上、用途別
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカにおける核酸医薬品原料、国別
8.1.1 中東・アフリカにおける核酸医薬品原料の売上規模、国別（2018年～2023年）
8.1.2 中東・アフリカにおける核酸医薬品原料市場の収益規模、国別（2018年～2023年）
8.2 中東・アフリカにおける核酸医薬品原料の売上、タイプ別
8.3 中東・アフリカにおける核酸医薬品原料の売上、用途別
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 製造コスト構造分析
10.1 原料・サプライヤー
10.2 核酸医薬品原料の製造コスト構造分析
10.3 核酸医薬品原料の製造プロセス分析
10.4 核酸医薬品原料のインダストリーチェーン構造
11 マーケティング・流通・顧客
11.1 販売チャネル
11.1.1 直接チャネル
11.1.2 間接チャネル
11.2 核酸医薬品原料の流通業者
11.3 核酸医薬品原料の顧客
12 核酸医薬品原料の世界市場予測レビュー、地理別
12.1 グローバルにおける核酸医薬品原料の市場規模予測、地域別
12.1.1 グローバルの核酸医薬品原料、市場予測（地域別）（2024年～2029年）
12.1.2 グローバルの核酸医薬品原料、年間収益予測（地域別）（2024年～2029年）
12.2 アメリカズにおける予測、国別
12.3 APACにおける予測、地域別
12.4 ヨーロッパにおける予測、国別
12.5 中東・アフリカにおける予測、国別
12.6 グローバルにおける核酸医薬品原料の市場予測、タイプ別
12.7 グローバルにおける核酸医薬品原料の市場予測、用途別
13 キープレイヤー分析
13.1 Danaher Corporation
13.1.1 Danaher Corporation：企業情報
13.1.2 Danaher Corporation：核酸医薬品原料製品ポートフォリオと特徴
13.1.3 Danaher Corporation：核酸医薬品原料売上・収益・価格およびグロスマージン（2018年～2023年）
13.1.4 Danaher Corporation：主要事業概要
13.1.5 Danaher Corporation：直近の展開
13.2 Merck
13.2.1 Merck：企業情報
13.2.2 Merck：核酸医薬品原料製品ポートフォリオと特徴
13.2.3 Merck：核酸医薬品原料売上・収益・価格およびグロスマージン（2018年～2023年）
13.2.4 Merck：主要事業概要
13.2.5 Merck：直近の展開
13.3 Eurofins Scientific
13.3.1 Eurofins Scientific：企業情報
13.3.2 Eurofins Scientific：核酸医薬品原料製品ポートフォリオと特徴
13.3.3 Eurofins Scientific：核酸医薬品原料売上・収益・価格およびグロスマージン（2018年～2023年）
13.3.4 Eurofins Scientific：主要事業概要
13.3.5 Eurofins Scientific：直近の展開
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific：企業情報
13.4.2 Thermo Fisher Scientific：核酸医薬品原料製品ポートフォリオと特徴
13.4.3 Thermo Fisher Scientific：核酸医薬品原料売上・収益・価格およびグロスマージン（2018年～2023年）
13.4.4 Thermo Fisher Scientific：主要事業概要
13.4.5 Thermo Fisher Scientific：直近の展開
13.5 Agilent Technologies
13.5.1 Agilent Technologies：企業情報
13.5.2 Agilent Technologies：核酸医薬品原料製品ポートフォリオと特徴
13.5.3 Agilent Technologies：核酸医薬品原料売上・収益・価格およびグロスマージン（2018年～2023年）
13.5.4 Agilent Technologies：主要事業概要
13.5.5 Agilent Technologies：直近の展開
13.6 GE Healthcare
13.6.1 GE Healthcare：企業情報
13.6.2 GE Healthcare：核酸医薬品原料製品ポートフォリオと特徴
13.6.3 GE Healthcare：核酸医薬品原料売上・収益・価格およびグロスマージン（2018年～2023年）
13.6.4 GE Healthcare：主要事業概要
13.6.5 GE Healthcare：直近の展開
13.7 Kaneka Eurogentec
13.7.1 Kaneka Eurogentec：企業情報
13.7.2 Kaneka Eurogentec：核酸医薬品原料製品ポートフォリオと特徴
13.7.3 Kaneka Eurogentec：核酸医薬品原料売上・収益・価格およびグロスマージン（2018年～2023年）
13.7.4 Kaneka Eurogentec：主要事業概要
13.7.5 Kaneka Eurogentec：直近の展開
13.8 GeneDesign
13.8.1 GeneDesign：企業情報
13.8.2 GeneDesign：核酸医薬品原料製品ポートフォリオと特徴
13.8.3 GeneDesign：核酸医薬品原料売上・収益・価格およびグロスマージン（2018年～2023年）
13.8.4 GeneDesign：主要事業概要
13.8.5 GeneDesign：直近の展開
13.9 LGC Biosearch Technologies
13.9.1 LGC Biosearch Technologies：企業情報
13.9.2 LGC Biosearch Technologies：核酸医薬品原料製品ポートフォリオと特徴
13.9.3 LGC Biosearch Technologies：核酸医薬品原料売上・収益・価格およびグロスマージン（2018年～2023年）
13.9.4 LGC Biosearch Technologies：主要事業概要
13.9.5 LGC Biosearch Technologies：直近の展開
13.10 Bio-synthesis
13.10.1 Bio-synthesis：企業情報
13.10.2 Bio-synthesis：核酸医薬品原料製品ポートフォリオと特徴
13.10.3 Bio-synthesis：核酸医薬品原料売上・収益・価格およびグロスマージン（2018年～2023年）
13.10.4 Bio-synthesis：主要事業概要
13.10.5 Bio-synthesis：直近の展開
13.11 Guangzhou RiboBio
13.11.1 Guangzhou RiboBio：企業情報
13.11.2 Guangzhou RiboBio：核酸医薬品原料製品ポートフォリオと特徴
13.11.3 Guangzhou RiboBio：核酸医薬品原料売上・収益・価格およびグロスマージン（2018年～2023年）
13.11.4 Guangzhou RiboBio：主要事業概要
13.11.5 Guangzhou RiboBio：直近の展開
13.12 STA Pharmaceutical
13.12.1 STA Pharmaceutical：企業情報
13.12.2 STA Pharmaceutical：核酸医薬品原料製品ポートフォリオと特徴
13.12.3 STA Pharmaceutical：核酸医薬品原料売上・収益・価格およびグロスマージン（2018年～2023年）
13.12.4 STA Pharmaceutical：主要事業概要
13.12.5 STA Pharmaceutical：直近の展開
13.13 Hongene Biotech
13.13.1 Hongene Biotech：企業情報
13.13.2 Hongene Biotech：核酸医薬品原料製品ポートフォリオと特徴
13.13.3 Hongene Biotech：核酸医薬品原料売上・収益・価格およびグロスマージン（2018年～2023年）
13.13.4 Hongene Biotech：主要事業概要
13.13.5 Hongene Biotech：直近の展開
14 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
LPI (LP Information)' newest research report, the “Nucleic Acid Drug Raw Materials Industry Forecast” looks at past sales and reviews total world Nucleic Acid Drug Raw Materials sales in 2022, providing a comprehensive analysis by region and market sector of projected Nucleic Acid Drug Raw Materials sales for 2023 through 2029. With Nucleic Acid Drug Raw Materials sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acid Drug Raw Materials industry.
This Insight Report provides a comprehensive analysis of the global Nucleic Acid Drug Raw Materials landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nucleic Acid Drug Raw Materials portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Nucleic Acid Drug Raw Materials market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acid Drug Raw Materials and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acid Drug Raw Materials.
The global Nucleic Acid Drug Raw Materials market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Nucleic Acid Drug Raw Materials is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nucleic Acid Drug Raw Materials is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nucleic Acid Drug Raw Materials is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nucleic Acid Drug Raw Materials players cover Danaher Corporation, Merck, Eurofins Scientific, Thermo Fisher Scientific, Agilent Technologies, GE Healthcare, Kaneka Eurogentec, GeneDesign and LGC Biosearch Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Drug Raw Materials market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
ASO
siRNA
Other
Segmentation by application
Research
Pharmaceutical
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Danaher Corporation
Merck
Eurofins Scientific
Thermo Fisher Scientific
Agilent Technologies
GE Healthcare
Kaneka Eurogentec
GeneDesign
LGC Biosearch Technologies
Bio-synthesis
Guangzhou RiboBio
STA Pharmaceutical
Hongene Biotech
Key Questions Addressed in this Report
What is the 10-year outlook for the global Nucleic Acid Drug Raw Materials market?
What factors are driving Nucleic Acid Drug Raw Materials market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nucleic Acid Drug Raw Materials market opportunities vary by end market size?
How does Nucleic Acid Drug Raw Materials break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nucleic Acid Drug Raw Materials Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Nucleic Acid Drug Raw Materials by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Nucleic Acid Drug Raw Materials by Country/Region, 2018, 2022 & 2029
2.2 Nucleic Acid Drug Raw Materials Segment by Type
2.2.1 ASO
2.2.2 siRNA
2.2.3 Other
2.3 Nucleic Acid Drug Raw Materials Sales by Type
2.3.1 Global Nucleic Acid Drug Raw Materials Sales Market Share by Type (2018-2023)
2.3.2 Global Nucleic Acid Drug Raw Materials Revenue and Market Share by Type (2018-2023)
2.3.3 Global Nucleic Acid Drug Raw Materials Sale Price by Type (2018-2023)
2.4 Nucleic Acid Drug Raw Materials Segment by Application
2.4.1 Research
2.4.2 Pharmaceutical
2.4.3 Other
2.5 Nucleic Acid Drug Raw Materials Sales by Application
2.5.1 Global Nucleic Acid Drug Raw Materials Sale Market Share by Application (2018-2023)
2.5.2 Global Nucleic Acid Drug Raw Materials Revenue and Market Share by Application (2018-2023)
2.5.3 Global Nucleic Acid Drug Raw Materials Sale Price by Application (2018-2023)
3 Global Nucleic Acid Drug Raw Materials by Company
3.1 Global Nucleic Acid Drug Raw Materials Breakdown Data by Company
3.1.1 Global Nucleic Acid Drug Raw Materials Annual Sales by Company (2018-2023)
3.1.2 Global Nucleic Acid Drug Raw Materials Sales Market Share by Company (2018-2023)
3.2 Global Nucleic Acid Drug Raw Materials Annual Revenue by Company (2018-2023)
3.2.1 Global Nucleic Acid Drug Raw Materials Revenue by Company (2018-2023)
3.2.2 Global Nucleic Acid Drug Raw Materials Revenue Market Share by Company (2018-2023)
3.3 Global Nucleic Acid Drug Raw Materials Sale Price by Company
3.4 Key Manufacturers Nucleic Acid Drug Raw Materials Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nucleic Acid Drug Raw Materials Product Location Distribution
3.4.2 Players Nucleic Acid Drug Raw Materials Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nucleic Acid Drug Raw Materials by Geographic Region
4.1 World Historic Nucleic Acid Drug Raw Materials Market Size by Geographic Region (2018-2023)
4.1.1 Global Nucleic Acid Drug Raw Materials Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Nucleic Acid Drug Raw Materials Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Nucleic Acid Drug Raw Materials Market Size by Country/Region (2018-2023)
4.2.1 Global Nucleic Acid Drug Raw Materials Annual Sales by Country/Region (2018-2023)
4.2.2 Global Nucleic Acid Drug Raw Materials Annual Revenue by Country/Region (2018-2023)
4.3 Americas Nucleic Acid Drug Raw Materials Sales Growth
4.4 APAC Nucleic Acid Drug Raw Materials Sales Growth
4.5 Europe Nucleic Acid Drug Raw Materials Sales Growth
4.6 Middle East & Africa Nucleic Acid Drug Raw Materials Sales Growth
5 Americas
5.1 Americas Nucleic Acid Drug Raw Materials Sales by Country
5.1.1 Americas Nucleic Acid Drug Raw Materials Sales by Country (2018-2023)
5.1.2 Americas Nucleic Acid Drug Raw Materials Revenue by Country (2018-2023)
5.2 Americas Nucleic Acid Drug Raw Materials Sales by Type
5.3 Americas Nucleic Acid Drug Raw Materials Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid Drug Raw Materials Sales by Region
6.1.1 APAC Nucleic Acid Drug Raw Materials Sales by Region (2018-2023)
6.1.2 APAC Nucleic Acid Drug Raw Materials Revenue by Region (2018-2023)
6.2 APAC Nucleic Acid Drug Raw Materials Sales by Type
6.3 APAC Nucleic Acid Drug Raw Materials Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nucleic Acid Drug Raw Materials by Country
7.1.1 Europe Nucleic Acid Drug Raw Materials Sales by Country (2018-2023)
7.1.2 Europe Nucleic Acid Drug Raw Materials Revenue by Country (2018-2023)
7.2 Europe Nucleic Acid Drug Raw Materials Sales by Type
7.3 Europe Nucleic Acid Drug Raw Materials Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nucleic Acid Drug Raw Materials by Country
8.1.1 Middle East & Africa Nucleic Acid Drug Raw Materials Sales by Country (2018-2023)
8.1.2 Middle East & Africa Nucleic Acid Drug Raw Materials Revenue by Country (2018-2023)
8.2 Middle East & Africa Nucleic Acid Drug Raw Materials Sales by Type
8.3 Middle East & Africa Nucleic Acid Drug Raw Materials Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nucleic Acid Drug Raw Materials
10.3 Manufacturing Process Analysis of Nucleic Acid Drug Raw Materials
10.4 Industry Chain Structure of Nucleic Acid Drug Raw Materials
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nucleic Acid Drug Raw Materials Distributors
11.3 Nucleic Acid Drug Raw Materials Customer
12 World Forecast Review for Nucleic Acid Drug Raw Materials by Geographic Region
12.1 Global Nucleic Acid Drug Raw Materials Market Size Forecast by Region
12.1.1 Global Nucleic Acid Drug Raw Materials Forecast by Region (2024-2029)
12.1.2 Global Nucleic Acid Drug Raw Materials Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nucleic Acid Drug Raw Materials Forecast by Type
12.7 Global Nucleic Acid Drug Raw Materials Forecast by Application
13 Key Players Analysis
13.1 Danaher Corporation
13.1.1 Danaher Corporation Company Information
13.1.2 Danaher Corporation Nucleic Acid Drug Raw Materials Product Portfolios and Specifications
13.1.3 Danaher Corporation Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Danaher Corporation Main Business Overview
13.1.5 Danaher Corporation Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Nucleic Acid Drug Raw Materials Product Portfolios and Specifications
13.2.3 Merck Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Eurofins Scientific
13.3.1 Eurofins Scientific Company Information
13.3.2 Eurofins Scientific Nucleic Acid Drug Raw Materials Product Portfolios and Specifications
13.3.3 Eurofins Scientific Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Eurofins Scientific Main Business Overview
13.3.5 Eurofins Scientific Latest Developments
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Information
13.4.2 Thermo Fisher Scientific Nucleic Acid Drug Raw Materials Product Portfolios and Specifications
13.4.3 Thermo Fisher Scientific Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Thermo Fisher Scientific Main Business Overview
13.4.5 Thermo Fisher Scientific Latest Developments
13.5 Agilent Technologies
13.5.1 Agilent Technologies Company Information
13.5.2 Agilent Technologies Nucleic Acid Drug Raw Materials Product Portfolios and Specifications
13.5.3 Agilent Technologies Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Agilent Technologies Main Business Overview
13.5.5 Agilent Technologies Latest Developments
13.6 GE Healthcare
13.6.1 GE Healthcare Company Information
13.6.2 GE Healthcare Nucleic Acid Drug Raw Materials Product Portfolios and Specifications
13.6.3 GE Healthcare Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 GE Healthcare Main Business Overview
13.6.5 GE Healthcare Latest Developments
13.7 Kaneka Eurogentec
13.7.1 Kaneka Eurogentec Company Information
13.7.2 Kaneka Eurogentec Nucleic Acid Drug Raw Materials Product Portfolios and Specifications
13.7.3 Kaneka Eurogentec Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Kaneka Eurogentec Main Business Overview
13.7.5 Kaneka Eurogentec Latest Developments
13.8 GeneDesign
13.8.1 GeneDesign Company Information
13.8.2 GeneDesign Nucleic Acid Drug Raw Materials Product Portfolios and Specifications
13.8.3 GeneDesign Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 GeneDesign Main Business Overview
13.8.5 GeneDesign Latest Developments
13.9 LGC Biosearch Technologies
13.9.1 LGC Biosearch Technologies Company Information
13.9.2 LGC Biosearch Technologies Nucleic Acid Drug Raw Materials Product Portfolios and Specifications
13.9.3 LGC Biosearch Technologies Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 LGC Biosearch Technologies Main Business Overview
13.9.5 LGC Biosearch Technologies Latest Developments
13.10 Bio-synthesis
13.10.1 Bio-synthesis Company Information
13.10.2 Bio-synthesis Nucleic Acid Drug Raw Materials Product Portfolios and Specifications
13.10.3 Bio-synthesis Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Bio-synthesis Main Business Overview
13.10.5 Bio-synthesis Latest Developments
13.11 Guangzhou RiboBio
13.11.1 Guangzhou RiboBio Company Information
13.11.2 Guangzhou RiboBio Nucleic Acid Drug Raw Materials Product Portfolios and Specifications
13.11.3 Guangzhou RiboBio Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Guangzhou RiboBio Main Business Overview
13.11.5 Guangzhou RiboBio Latest Developments
13.12 STA Pharmaceutical
13.12.1 STA Pharmaceutical Company Information
13.12.2 STA Pharmaceutical Nucleic Acid Drug Raw Materials Product Portfolios and Specifications
13.12.3 STA Pharmaceutical Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 STA Pharmaceutical Main Business Overview
13.12.5 STA Pharmaceutical Latest Developments
13.13 Hongene Biotech
13.13.1 Hongene Biotech Company Information
13.13.2 Hongene Biotech Nucleic Acid Drug Raw Materials Product Portfolios and Specifications
13.13.3 Hongene Biotech Nucleic Acid Drug Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Hongene Biotech Main Business Overview
13.13.5 Hongene Biotech Latest Developments
14 Research Findings and Conclusion
List of Tables Table 1. Nucleic Acid Drug Raw Materials Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Nucleic Acid Drug Raw Materials Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of ASO Table 4. Major Players of siRNA Table 5. Major Players of Other Table 6. Global Nucleic Acid Drug Raw Materials Sales by Type (2018-2023) & (Tons) Table 7. Global Nucleic Acid Drug Raw Materials Sales Market Share by Type (2018-2023) Table 8. Global Nucleic Acid Drug Raw Materials Revenue by Type (2018-2023) & ($ million) Table 9. Global Nucleic Acid Drug Raw Materials Revenue Market Share by Type (2018-2023) Table 10. Global Nucleic Acid Drug Raw Materials Sale Price by Type (2018-2023) & (US$/Ton) Table 11. Global Nucleic Acid Drug Raw Materials Sales by Application (2018-2023) & (Tons) Table 12. Global Nucleic Acid Drug Raw Materials Sales Market Share by Application (2018-2023) Table 13. Global Nucleic Acid Drug Raw Materials Revenue by Application (2018-2023) Table 14. Global Nucleic Acid Drug Raw Materials Revenue Market Share by Application (2018-2023) Table 15. Global Nucleic Acid Drug Raw Materials Sale Price by Application (2018-2023) & (US$/Ton) Table 16. Global Nucleic Acid Drug Raw Materials Sales by Company (2018-2023) & (Tons) Table 17. Global Nucleic Acid Drug Raw Materials Sales Market Share by Company (2018-2023) Table 18. Global Nucleic Acid Drug Raw Materials Revenue by Company (2018-2023) ($ Millions) Table 19. Global Nucleic Acid Drug Raw Materials Revenue Market Share by Company (2018-2023) Table 20. Global Nucleic Acid Drug Raw Materials Sale Price by Company (2018-2023) & (US$/Ton) Table 21. Key Manufacturers Nucleic Acid Drug Raw Materials Producing Area Distribution and Sales Area Table 22. Players Nucleic Acid Drug Raw Materials Products Offered Table 23. Nucleic Acid Drug Raw Materials Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global Nucleic Acid Drug Raw Materials Sales by Geographic Region (2018-2023) & (Tons) Table 27. Global Nucleic Acid Drug Raw Materials Sales Market Share Geographic Region (2018-2023) Table 28. Global Nucleic Acid Drug Raw Materials Revenue by Geographic Region (2018-2023) & ($ millions) Table 29. Global Nucleic Acid Drug Raw Materials Revenue Market Share by Geographic Region (2018-2023) Table 30. Global Nucleic Acid Drug Raw Materials Sales by Country/Region (2018-2023) & (Tons) Table 31. Global Nucleic Acid Drug Raw Materials Sales Market Share by Country/Region (2018-2023) Table 32. Global Nucleic Acid Drug Raw Materials Revenue by Country/Region (2018-2023) & ($ millions) Table 33. Global Nucleic Acid Drug Raw Materials Revenue Market Share by Country/Region (2018-2023) Table 34. Americas Nucleic Acid Drug Raw Materials Sales by Country (2018-2023) & (Tons) Table 35. Americas Nucleic Acid Drug Raw Materials Sales Market Share by Country (2018-2023) Table 36. Americas Nucleic Acid Drug Raw Materials Revenue by Country (2018-2023) & ($ Millions) Table 37. Americas Nucleic Acid Drug Raw Materials Revenue Market Share by Country (2018-2023) Table 38. Americas Nucleic Acid Drug Raw Materials Sales by Type (2018-2023) & (Tons) Table 39. Americas Nucleic Acid Drug Raw Materials Sales by Application (2018-2023) & (Tons) Table 40. APAC Nucleic Acid Drug Raw Materials Sales by Region (2018-2023) & (Tons) Table 41. APAC Nucleic Acid Drug Raw Materials Sales Market Share by Region (2018-2023) Table 42. APAC Nucleic Acid Drug Raw Materials Revenue by Region (2018-2023) & ($ Millions) Table 43. APAC Nucleic Acid Drug Raw Materials Revenue Market Share by Region (2018-2023) Table 44. APAC Nucleic Acid Drug Raw Materials Sales by Type (2018-2023) & (Tons) Table 45. APAC Nucleic Acid Drug Raw Materials Sales by Application (2018-2023) & (Tons) Table 46. Europe Nucleic Acid Drug Raw Materials Sales by Country (2018-2023) & (Tons) Table 47. Europe Nucleic Acid Drug Raw Materials Sales Market Share by Country (2018-2023) Table 48. Europe Nucleic Acid Drug Raw Materials Revenue by Country (2018-2023) & ($ Millions) Table 49. Europe Nucleic Acid Drug Raw Materials Revenue Market Share by Country (2018-2023) Table 50. Europe Nucleic Acid Drug Raw Materials Sales by Type (2018-2023) & (Tons) Table 51. Europe Nucleic Acid Drug Raw Materials Sales by Application (2018-2023) & (Tons) Table 52. Middle East & Africa Nucleic Acid Drug Raw Materials Sales by Country (2018-2023) & (Tons) Table 53. Middle East & Africa Nucleic Acid Drug Raw Materials Sales Market Share by Country (2018-2023) Table 54. Middle East & Africa Nucleic Acid Drug Raw Materials Revenue by Country (2018-2023) & ($ Millions) Table 55. Middle East & Africa Nucleic Acid Drug Raw Materials Revenue Market Share by Country (2018-2023) Table 56. Middle East & Africa Nucleic Acid Drug Raw Materials Sales by Type (2018-2023) & (Tons) Table 57. Middle East & Africa Nucleic Acid Drug Raw Materials Sales by Application (2018-2023) & (Tons) Table 58. Key Market Drivers & Growth Opportunities of Nucleic Acid Drug Raw Materials Table 59. Key Market Challenges & Risks of Nucleic Acid Drug Raw Materials Table 60. Key Industry Trends of Nucleic Acid Drug Raw Materials Table 61. Nucleic Acid Drug Raw Materials Raw Material Table 62. Key Suppliers of Raw Materials Table 63. Nucleic Acid Drug Raw Materials Distributors List Table 64. Nucleic Acid Drug Raw Materials Customer List Table 65. Global Nucleic Acid Drug Raw Materials Sales Forecast by Region (2024-2029) & (Tons) Table 66. Global Nucleic Acid Drug Raw Materials Revenue Forecast by Region (2024-2029) & ($ millions) Table 67. Americas Nucleic Acid Drug Raw Materials Sales Forecast by Country (2024-2029) & (Tons) Table 68. Americas Nucleic Acid Drug Raw Materials Revenue Forecast by Country (2024-2029) & ($ millions) Table 69. APAC Nucleic Acid Drug Raw Materials Sales Forecast by Region (2024-2029) & (Tons) Table 70. APAC Nucleic Acid Drug Raw Materials Revenue Forecast by Region (2024-2029) & ($ millions) Table 71. Europe Nucleic Acid Drug Raw Materials Sales Forecast by Country (2024-2029) & (Tons) Table 72. Europe Nucleic Acid Drug Raw Materials Revenue Forecast by Country (2024-2029) & ($ millions) Table 73. Middle East & Africa Nucleic Acid Drug Raw Materials Sales Forecast by Country (2024-2029) & (Tons) Table 74. Middle East & Africa Nucleic Acid Drug Raw Materials Revenue Forecast by Country (2024-2029) & ($ millions) Table 75. Global Nucleic Acid Drug Raw Materials Sales Forecast by Type (2024-2029) & (Tons) Table 76. Global Nucleic Acid Drug Raw Materials Revenue Forecast by Type (2024-2029) & ($ Millions) Table 77. Global Nucleic Acid Drug Raw Materials Sales Forecast by Application (2024-2029) & (Tons) Table 78. Global Nucleic Acid Drug Raw Materials Revenue Forecast by Application (2024-2029) & ($ Millions) Table 79. Danaher Corporation Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors Table 80. Danaher Corporation Nucleic Acid Drug Raw Materials Product Portfolios and Specifications Table 81. Danaher Corporation Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 82. Danaher Corporation Main Business Table 83. Danaher Corporation Latest Developments Table 84. Merck Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors Table 85. Merck Nucleic Acid Drug Raw Materials Product Portfolios and Specifications Table 86. Merck Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 87. Merck Main Business Table 88. Merck Latest Developments Table 89. Eurofins Scientific Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors Table 90. Eurofins Scientific Nucleic Acid Drug Raw Materials Product Portfolios and Specifications Table 91. Eurofins Scientific Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 92. Eurofins Scientific Main Business Table 93. Eurofins Scientific Latest Developments Table 94. Thermo Fisher Scientific Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors Table 95. Thermo Fisher Scientific Nucleic Acid Drug Raw Materials Product Portfolios and Specifications Table 96. Thermo Fisher Scientific Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 97. Thermo Fisher Scientific Main Business Table 98. Thermo Fisher Scientific Latest Developments Table 99. Agilent Technologies Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors Table 100. Agilent Technologies Nucleic Acid Drug Raw Materials Product Portfolios and Specifications Table 101. Agilent Technologies Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 102. Agilent Technologies Main Business Table 103. Agilent Technologies Latest Developments Table 104. GE Healthcare Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors Table 105. GE Healthcare Nucleic Acid Drug Raw Materials Product Portfolios and Specifications Table 106. GE Healthcare Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 107. GE Healthcare Main Business Table 108. GE Healthcare Latest Developments Table 109. Kaneka Eurogentec Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors Table 110. Kaneka Eurogentec Nucleic Acid Drug Raw Materials Product Portfolios and Specifications Table 111. Kaneka Eurogentec Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 112. Kaneka Eurogentec Main Business Table 113. Kaneka Eurogentec Latest Developments Table 114. GeneDesign Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors Table 115. GeneDesign Nucleic Acid Drug Raw Materials Product Portfolios and Specifications Table 116. GeneDesign Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 117. GeneDesign Main Business Table 118. GeneDesign Latest Developments Table 119. LGC Biosearch Technologies Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors Table 120. LGC Biosearch Technologies Nucleic Acid Drug Raw Materials Product Portfolios and Specifications Table 121. LGC Biosearch Technologies Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 122. LGC Biosearch Technologies Main Business Table 123. LGC Biosearch Technologies Latest Developments Table 124. Bio-synthesis Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors Table 125. Bio-synthesis Nucleic Acid Drug Raw Materials Product Portfolios and Specifications Table 126. Bio-synthesis Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 127. Bio-synthesis Main Business Table 128. Bio-synthesis Latest Developments Table 129. Guangzhou RiboBio Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors Table 130. Guangzhou RiboBio Nucleic Acid Drug Raw Materials Product Portfolios and Specifications Table 131. Guangzhou RiboBio Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 132. Guangzhou RiboBio Main Business Table 133. Guangzhou RiboBio Latest Developments Table 134. STA Pharmaceutical Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors Table 135. STA Pharmaceutical Nucleic Acid Drug Raw Materials Product Portfolios and Specifications Table 136. STA Pharmaceutical Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 137. STA Pharmaceutical Main Business Table 138. STA Pharmaceutical Latest Developments Table 139. Hongene Biotech Basic Information, Nucleic Acid Drug Raw Materials Manufacturing Base, Sales Area and Its Competitors Table 140. Hongene Biotech Nucleic Acid Drug Raw Materials Product Portfolios and Specifications Table 141. Hongene Biotech Nucleic Acid Drug Raw Materials Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 142. Hongene Biotech Main Business Table 143. Hongene Biotech Latest Developments List of Figures Figure 1. Picture of Nucleic Acid Drug Raw Materials Figure 2. Nucleic Acid Drug Raw Materials Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Nucleic Acid Drug Raw Materials Sales Growth Rate 2018-2029 (Tons) Figure 7. Global Nucleic Acid Drug Raw Materials Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Nucleic Acid Drug Raw Materials Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of ASO Figure 10. Product Picture of siRNA Figure 11. Product Picture of Other Figure 12. Global Nucleic Acid Drug Raw Materials Sales Market Share by Type in 2022 Figure 13. Global Nucleic Acid Drug Raw Materials Revenue Market Share by Type (2018-2023) Figure 14. Nucleic Acid Drug Raw Materials Consumed in Research Figure 15. Global Nucleic Acid Drug Raw Materials Market: Research (2018-2023) & (Tons) Figure 16. Nucleic Acid Drug Raw Materials Consumed in Pharmaceutical Figure 17. Global Nucleic Acid Drug Raw Materials Market: Pharmaceutical (2018-2023) & (Tons) Figure 18. Nucleic Acid Drug Raw Materials Consumed in Other Figure 19. Global Nucleic Acid Drug Raw Materials Market: Other (2018-2023) & (Tons) Figure 20. Global Nucleic Acid Drug Raw Materials Sales Market Share by Application (2022) Figure 21. Global Nucleic Acid Drug Raw Materials Revenue Market Share by Application in 2022 Figure 22. Nucleic Acid Drug Raw Materials Sales Market by Company in 2022 (Tons) Figure 23. Global Nucleic Acid Drug Raw Materials Sales Market Share by Company in 2022 Figure 24. Nucleic Acid Drug Raw Materials Revenue Market by Company in 2022 ($ Million) Figure 25. Global Nucleic Acid Drug Raw Materials Revenue Market Share by Company in 2022 Figure 26. Global Nucleic Acid Drug Raw Materials Sales Market Share by Geographic Region (2018-2023) Figure 27. Global Nucleic Acid Drug Raw Materials Revenue Market Share by Geographic Region in 2022 Figure 28. Americas Nucleic Acid Drug Raw Materials Sales 2018-2023 (Tons) Figure 29. Americas Nucleic Acid Drug Raw Materials Revenue 2018-2023 ($ Millions) Figure 30. APAC Nucleic Acid Drug Raw Materials Sales 2018-2023 (Tons) Figure 31. APAC Nucleic Acid Drug Raw Materials Revenue 2018-2023 ($ Millions) Figure 32. Europe Nucleic Acid Drug Raw Materials Sales 2018-2023 (Tons) Figure 33. Europe Nucleic Acid Drug Raw Materials Revenue 2018-2023 ($ Millions) Figure 34. Middle East & Africa Nucleic Acid Drug Raw Materials Sales 2018-2023 (Tons) Figure 35. Middle East & Africa Nucleic Acid Drug Raw Materials Revenue 2018-2023 ($ Millions) Figure 36. Americas Nucleic Acid Drug Raw Materials Sales Market Share by Country in 2022 Figure 37. Americas Nucleic Acid Drug Raw Materials Revenue Market Share by Country in 2022 Figure 38. Americas Nucleic Acid Drug Raw Materials Sales Market Share by Type (2018-2023) Figure 39. Americas Nucleic Acid Drug Raw Materials Sales Market Share by Application (2018-2023) Figure 40. United States Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 41. Canada Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 42. Mexico Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 43. Brazil Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 44. APAC Nucleic Acid Drug Raw Materials Sales Market Share by Region in 2022 Figure 45. APAC Nucleic Acid Drug Raw Materials Revenue Market Share by Regions in 2022 Figure 46. APAC Nucleic Acid Drug Raw Materials Sales Market Share by Type (2018-2023) Figure 47. APAC Nucleic Acid Drug Raw Materials Sales Market Share by Application (2018-2023) Figure 48. China Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 49. Japan Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 50. South Korea Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 51. Southeast Asia Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 52. India Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 53. Australia Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 54. China Taiwan Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 55. Europe Nucleic Acid Drug Raw Materials Sales Market Share by Country in 2022 Figure 56. Europe Nucleic Acid Drug Raw Materials Revenue Market Share by Country in 2022 Figure 57. Europe Nucleic Acid Drug Raw Materials Sales Market Share by Type (2018-2023) Figure 58. Europe Nucleic Acid Drug Raw Materials Sales Market Share by Application (2018-2023) Figure 59. Germany Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 60. France Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 61. UK Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 62. Italy Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 63. Russia Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 64. Middle East & Africa Nucleic Acid Drug Raw Materials Sales Market Share by Country in 2022 Figure 65. Middle East & Africa Nucleic Acid Drug Raw Materials Revenue Market Share by Country in 2022 Figure 66. Middle East & Africa Nucleic Acid Drug Raw Materials Sales Market Share by Type (2018-2023) Figure 67. Middle East & Africa Nucleic Acid Drug Raw Materials Sales Market Share by Application (2018-2023) Figure 68. Egypt Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 69. South Africa Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 70. Israel Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 71. Turkey Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 72. GCC Country Nucleic Acid Drug Raw Materials Revenue Growth 2018-2023 ($ Millions) Figure 73. Manufacturing Cost Structure Analysis of Nucleic Acid Drug Raw Materials in 2022 Figure 74. Manufacturing Process Analysis of Nucleic Acid Drug Raw Materials Figure 75. Industry Chain Structure of Nucleic Acid Drug Raw Materials Figure 76. Channels of Distribution Figure 77. Global Nucleic Acid Drug Raw Materials Sales Market Forecast by Region (2024-2029) Figure 78. Global Nucleic Acid Drug Raw Materials Revenue Market Share Forecast by Region (2024-2029) Figure 79. Global Nucleic Acid Drug Raw Materials Sales Market Share Forecast by Type (2024-2029) Figure 80. Global Nucleic Acid Drug Raw Materials Revenue Market Share Forecast by Type (2024-2029) Figure 81. Global Nucleic Acid Drug Raw Materials Sales Market Share Forecast by Application (2024-2029) Figure 82. Global Nucleic Acid Drug Raw Materials Revenue Market Share Forecast by Application (2024-2029)
